CJC-1295 DAC

Growth Hormone SecretagogueResearch Use Only

Also known as: CJC-1295 with DAC, Drug Affinity Complex GRF, DAC:GRF

A long-lasting growth-hormone-releasing peptide — one weekly injection keeps GH elevated for days.

Dosing quick reference

research reference

Starting dose

2 mg once weekly (1 mg conservative)

Frequency

Once weekly

Typical range

1–2 mg per week

Cycle

8–12 weeks on, then a 4-week break

Half-life

~6–8 days (extended by DAC albumin binding)

Route

Subcutaneous (research)

Common use

Studied as a GHRH analog for sustained stimulation of endogenous growth-hormone release

Common vial sizes

2 mg · 5 mg

Storage

Lyophilized powder stored refrigerated or frozen and protected from light; reconstituted solution refrigerated (2–8 °C) and used within several weeks

Stacking notes

Commonly discussed alongside a GHRP such as Ipamorelin to combine GHRH and secretagogue pathways

Reported side effects

Injection-site reactionWater retention reported anecdotallyHead or facial flushing reported anecdotallyTingling or numbness reported anecdotally

Regulatory note: Not an approved therapeutic; sold for research purposes only

Calculate a dose →CJC-1295 DAC on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.